PureTech Health plc
HealthcareNASDAQ:PRTC · NASDAQ Global Market
+$0.17 today
Vol 0.01M · Avg 0.01M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-11.17%
Period High
$19.84
Period Low
$14.50
Latest
$17.42
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Alumis Inc. Common Stock
NASDAQ:ALMS
$2.98B
Solid Biosciences Inc.
NASDAQ:SLDB
$556.28M
Neurogene Inc.
NASDAQ:NGNE
$459.84M
Autolus Therapeutics plc
NASDAQ:AUTL
$415.18M
Neumora Therapeutics, Inc. Common Stock
NASDAQ:NMRA
$329.81M
Lineage Cell Therapeutics, Inc.
AMEX:LCTX
$316.61M
Rocket Pharmaceuticals, Inc.
NASDAQ:RCKT
$300.28M
Benitec Biopharma Inc.
NASDAQ:BNTC
$293.44M
Quantum-Si incorporated
NASDAQ:QSI
$187.28M
ADC Therapeutics S.A.
NYSE:ADCT
$133.55M
What is the latest PRTC filing?
The latest filing shown is F-6 POS dated May 22, 2026.
How many recent filings does PRTC have?
Intrinsic Alpha currently shows 20 recent filings for PRTC.
Explore More
Continue the stock analysis
Jump to another research area for this company.